Keros Therapeutics (KROS) Cash from Operations Growth (5y) (2024 - 2025)
Keros Therapeutics (KROS) Cash from Operations Growth (5y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 381.52 Mn | 94.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.85% |
| Sep 30, 2025 | 18.12% |
| Jun 30, 2025 | -24.44% |
| Mar 31, 2025 | 85.30% |
| Dec 31, 2024 | -52.94% |
| Sep 30, 2024 | -59.50% |
| Jun 30, 2024 | -51.23% |
| Mar 31, 2024 | -77.73% |